Department of Oral and Maxillofacial Surgery, Tuebingen University Hospital, Tuebingen, Germany.
Head Neck. 2011 May;33(5):668-72. doi: 10.1002/hed.21502. Epub 2010 Aug 4.
Until now prognostic evaluation for patients with oral squamous cell carcinoma (OSCC) remains difficult. Thus, the aim of the present study was to ascertain the value of Ki-67 expression in predicting locoregional recurrence in OSCC.
In a large, homogeneous study population consisting of 166 patients with OSCC exclusively treated with primary surgery, expression of Ki-67 was investigated by immunohistochemistry.
We report that high proliferation significantly correlated to a higher risk of locoregional recurrence in stage I OSCC patients (p = .029). Carcinomas with a Ki-67 labeling index above the median showed a mean time to recurrence of 42 months, whereas mean time to recurrence was 55 months for those tumors below the median (p = .017).
This study provides the evidence of a predictive value of Ki-67 expression in stage I OSCC. Therefore, Ki-67 expression level could be used to identify a subgroup of surgically treated patients with stage I OSCC who might benefit from treatment intensification.
到目前为止,口腔鳞状细胞癌(OSCC)患者的预后评估仍然很困难。因此,本研究旨在确定 Ki-67 表达在预测 OSCC 局部区域复发中的价值。
在一个由 166 例仅接受原发性手术治疗的 OSCC 患者组成的大型同质研究人群中,通过免疫组织化学检测 Ki-67 的表达。
我们报告称,高增殖与 I 期 OSCC 患者局部区域复发的风险增加显著相关(p =.029)。Ki-67 标记指数高于中位数的癌的复发中位时间为 42 个月,而低于中位数的肿瘤的复发中位时间为 55 个月(p =.017)。
本研究提供了 Ki-67 表达在 I 期 OSCC 中具有预测价值的证据。因此,Ki-67 表达水平可用于识别接受手术治疗的 I 期 OSCC 患者亚组,这些患者可能受益于治疗强化。